Severe anaphylaxis caused by intravenous anti‐cancer drugs

Severe anaphylaxis caused by intravenous anti‐cancer drugs

Abstract Background The incidence and risk factors of severe anaphylaxis by intravenous anti‐cancer drugs are unclear, whereas those of milder reactions have been reported. Study Design Electronic medical charts of cancer patients who have undergone intravenous chemotherapy between January 2013 and...

Celý popis

Podrobná bibliografie
Hlavní autoři: Nobuyuki Horita, Etsuko Miyagi, Taichi Mizushima, Maki Hagihara, Chiaki Hata, Yuki Hattori, Narihiko Hayashi, Kuniyasu Irie, Hideyuki Ishikawa, Yusuke Kawabata, Yosuke Kitani, Noritoshi Kobayashi, Nobuaki Kobayashi, Yusuke Kurita, Yohei Miyake, Kentaro Miyake, Senri Oguri, Ichiro Ota, Ayako Shimizu, Masanobu Takeuchi, Akimitsu Yamada, Kojiro Yamamoto, Norio Yukawa, Munetaka Masuda, Nobuhiko Oridate, Yasushi Ichikawa, Takeshi Kaneko
Médium: Článek
Jazyk:English
Vydáno: Wiley 2021-10-01
Edice:Cancer Medicine
Témata:
anaphylaxis
drug hypersensitivity
medical oncology
retrospective studies
On-line přístup:https://doi.org/10.1002/cam4.4252

Internet

https://doi.org/10.1002/cam4.4252

Podobné jednotky